Slight downturn in Boston Scientifics Q2
Interventional device developer Boston Scientific revenues and adjusted net income showed a slight dip for its fiscal 2007 second quarter, end-June 30, compared with results from the Natick, Mass.-based firm’s 2006 second quarter results.
For the period, net sales were $2.071 billion, compared with $2.110 billion for the second quarter of 2006 and $2.086 billion for the first quarter of 2007. Adjusted net income for the quarter, excluding net special charges and amortization and stock compensation expense, was $271 million. Adjusted net income for the second quarter of 2006, excluding net special charges and amortization and stock compensation expense, was $412 million.
The company said that it estimates net sales for the third quarter this year to be between $2 billion and $2.1 billion.
For the period, net sales were $2.071 billion, compared with $2.110 billion for the second quarter of 2006 and $2.086 billion for the first quarter of 2007. Adjusted net income for the quarter, excluding net special charges and amortization and stock compensation expense, was $271 million. Adjusted net income for the second quarter of 2006, excluding net special charges and amortization and stock compensation expense, was $412 million.
The company said that it estimates net sales for the third quarter this year to be between $2 billion and $2.1 billion.